PREDICTIVE ONCOLOGY INC. (AIPT) financial statements (2021 and earlier)
Company profile
| Business Address |
2915 COMMERS DRIVE, EAGAN, MN 55121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 0 | 1 | 2 | 5 | 0 | |||
| Cash and cash equivalents | 0 | 1 | 2 | 5 | 0 | |||
| Receivables | 1 | 1 | 0 | 0 | 0 | |||
| Inventory, net of allowances, customer advances and progress billings | 0 | 0 | 0 | 0 | 0 | |||
| Inventory | 0 | 0 | 0 | 0 | 0 | |||
| Other undisclosed current assets | 0 | 1 | 1 | 0 | 0 | |||
| Total current assets: | 1 | 2 | 3 | 5 | 1 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | |||
| Long-term investments and receivables | 1 | 1 | ||||||
| Accounts and financing receivable, after allowance for credit loss | 1 | 1 | ||||||
| Intangible assets, net (including goodwill) | 1 | 0 | 0 | 0 | 0 | |||
| Intangible assets, net (excluding goodwill) | 1 | 0 | 0 | 0 | 0 | |||
| Total noncurrent assets: | 2 | 1 | 0 | 0 | 0 | |||
| TOTAL ASSETS: | 4 | 4 | 3 | 6 | 1 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 2 | 1 | 2 | 2 | 5 | |||
| Accounts payable | 0 | 0 | 0 | 1 | 2 | |||
| Accrued liabilities | 1 | 1 | 1 | 1 | 3 | |||
| Debt | 2 | 1 | ||||||
| Derivative instruments and hedges, liabilities | 0 | |||||||
| Estimated litigation liability | 0 | |||||||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 0 | 0 | ||
| Contract with customer, liability | ✕ | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | (0) | |||||||
| Total current liabilities: | 4 | 1 | 2 | 2 | 6 | |||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 0 | |||||||
| Accounts payable and accrued liabilities | 0 | |||||||
| Other undisclosed noncurrent liabilities | 0 | |||||||
| Total noncurrent liabilities: | 0 | 0 | ||||||
| Total liabilities: | 4 | 1 | 2 | 2 | 6 | |||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 0 | 3 | 1 | 4 | (6) | |||
| Preferred stock | 0 | |||||||
| Common stock | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 63 | 57 | 48 | 45 | 30 | |||
| Accumulated other comprehensive income | 0 | |||||||
| Accumulated deficit | (63) | (55) | (47) | (40) | ||||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | 0 | 0 | (36) | |||
| Total stockholders' equity: | 0 | 3 | 1 | 4 | (6) | |||
| TOTAL LIABILITIES AND EQUITY: | 4 | 4 | 3 | 6 | 1 | |||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 1 | 1 | 0 | 1 | 1 | ||
| Revenue, net | ✕ | ✕ | 1 | 0 | 1 | 1 | |
| Cost of revenue (Cost of Goods and Services Sold) | (0) | (0) | (0) | (0) | (0) | ||
| Gross profit: | 1 | 1 | 0 | 0 | 1 | ||
| Operating expenses | (8) | (8) | (7) | (5) | (7) | ||
| Operating loss: | (7) | (8) | (7) | (4) | (6) | ||
| Nonoperating income | 0 | 0 | |||||
| Investment income, nonoperating | 0 | ||||||
| Other nonoperating income | 0 | ||||||
| Interest and debt expense | (0) | (0) | (0) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (7) | (8) | (7) | (5) | (7) | ||
| Loss from equity method investments | (2) | ||||||
| Net loss attributable to parent: | (9) | (8) | (7) | (5) | (7) | ||
| Other undisclosed net loss available to common stockholders, basic | (1) | ||||||
| Net loss available to common stockholders, diluted: | (10) | (8) | (7) | (5) | (7) | ||
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (9) | (8) | (7) | (5) | (7) | ||
| Comprehensive loss: | (9) | (8) | (7) | (5) | (7) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 0 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (9) | (8) | (7) | (5) | (7) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.